Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms – A Randomized Clinical Trial

After years of research, Dr. Lipov’s treatment has been proven – by a now-published clinical trial – to make “a significant difference” for veterans with PTSD.

From the article: 
Key Points

Question  How does stellate ganglion block compare with sham treatment in reducing the severity of posttraumatic stress disorder symptoms over 8 weeks?

Findings  In this sham-controlled randomized clinical trial, 2 stellate ganglion block treatments 2 weeks apart were effective in reducing Clinician-Administered PTSD Scale for DSM-5 total symptom severity scores over 8 weeks. The adjusted mean symptom change was −12.6 points for the group receiving stellate ganglion blocks, compared with −6.1 points for those receiving sham treatment, a significant difference.

Meaning  Stellate ganglion block treatment warrants further study as a posttraumatic stress disorder treatment adjunct.

###

Click here to read in the Journal of the American Medical Association

Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms – A Randomized Clinical Trial

After years of research, Dr. Lipov’s treatment has been proven – by a now-published clinical trial – to make “a significant difference” for veterans with PTSD.

From the article: 
Key Points

Question  How does stellate ganglion block compare with sham treatment in reducing the severity of posttraumatic stress disorder symptoms over 8 weeks?

Findings  In this sham-controlled randomized clinical trial, 2 stellate ganglion block treatments 2 weeks apart were effective in reducing Clinician-Administered PTSD Scale for DSM-5 total symptom severity scores over 8 weeks. The adjusted mean symptom change was −12.6 points for the group receiving stellate ganglion blocks, compared with −6.1 points for those receiving sham treatment, a significant difference.

Meaning  Stellate ganglion block treatment warrants further study as a posttraumatic stress disorder treatment adjunct.

###

Click here to read in the Journal of the American Medical Association

Medal of Honor recipient praises revolutionary neck injection treatment for PTSD

Story from Military Times

18 June 2019

A therapy for post-traumatic stress disorder that some doctors believe will “revolutionize the way PTSD is handled” was the subject of a recent “60 Minutes” report featuring a number of afflicted veterans, including one Medal of Honor recipient.

The breakthrough treatment, called stellate ganglion block, or SGB, has been shown to significantly diminish various symptoms of PTSD, such as depression, anxiety, and insomnia.

Read more here

Treating PTSD with the Stellate Ganglion Block with Navy Veteran Meriwether Ball

 

Story from VeteranOnTheMove.com

25 February 2019

Meriwether Ball, USMC historian and journalist, has provided pro-bono public affairs effort for Dr. Eugene Lipov since her successful treatment, relieving her of 50 years of symptoms.  Dr. Eugene Lipov is the pioneering anesthesiologist who developed the Lipov Block, the stellate ganglion block for treatment of PTSD.

I don’t have flashbacks, nightmares anymore and I have to tell you that it was so unfamiliar.  The first thing I said, Greg asked me how do I feel and I said, it’s so noisy in here. He said that’s something, a lot of people who have had the block experience that the noise in your head is so loud.  I didn’t realize that flashbacks had audio. – Meriwether Ball

Read more here…

‘It could make a difference in a lot of dogs’: Doctor tries PTSD treatment for first time on animal

Story from DailyHerald.com

14 September 2018

By Burt Constable, Editor

A service dog for an Iraq War veteran suffering from post-traumatic stress disorder, gentle Reno developed his own PTSD in November after he was pinned under a crashed van and suffered burns.

“He displayed a lot of anxiety,” says owner Sonia Campos-Marchiori, who with her husband, Paul Marchiori, founded the V.E.T. Service Dogs charity that trained Reno and other service dogs. “He was tearing couches up and pulling curtains down.”

Reno barks loudly, growls and snarls as he’s led into the Veterinary Specialty Center in Buffalo Grove…

Click here for rest of story and video

CONTACT: Patients Seeking Lipov Block (SGB)

Patient forms: hover HERE then click on blue hyperlink for forms, or call/email Greg Alberth, Dr. Lipov’s Research Assistant :

Call 844.SGB.PTSI or Email: hope4ptsi@gmail.com

Thank you!

V.A. Evidence Brief: Effectiveness of Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder (PTSD) (pdf enclosed)

Publication: Department of Veterans Affairs, Veterans Health Administration,Quality Enhancement Research Initiative, Health Services Research & Development Service
Washington, DC 20420
Date: February 2017
Author: Evidence-based Synthesis Program (ESP), Coordinating Center, Portland VA Health Care System, Portland, OR, Mark Helfand, MD, MPH, MS, Director

Summary:
Emergence of an intervention’s first randomized trial is always a highly anticipated event. For SGB, however, findings from its first randomized trial for PTSD proved to be disappointing. In uncontrolled, unblinded, retrospective case series, SGB for PTSD had high rates of rapid clinical improvement in PTSD symptoms (70% to 75%). In the RCT, the range of mean percent PTSD improvement after one round of SGB was 5.4% to 14.7%, and was 12.1% to 21.2% after the second round, which was no better than an injection of saline. The RCT was too small to estimate complication rates and did not report the number of patients in each group, if any, who responded to treatment. Instead it reported group averages. What do we make of this? It is not surprising that SGB’s benefits were less impressive in the RCT than in the case series, as empirical evaluation has shown that, on average, benefits are generally larger in observational studies.66 However, what was surprising is that by using a somewhat lower than usual dose of ropivacaine (5 cc versus 7 cc) and a population that may have been motivated to resist treatment, design features may have limited the RCT’s chances of generating meaningful data on efficacy.71 Substantial uncertainty remains about the potential harms of SGB as well, as the RCT and previous case series in PTSD, as well as RCTs for CRPS, 68 were inadequately powered to support or refute findings from the 1992 German questionnaire survey of 45,000 SGBs. We agree with the conclusions of previous reviews that further research is needed to more precisely determine the balance of benefits and harms of SGB for PTSD.39,52,72.

SA-Lipov-VA-evidence-brief-stellate-ganglion-block

###

Please help veterans/service members receive this treatment by donating to Dr. Lipov’s Foundation: http://globalptsifoundation.org/donate